Despite a recent rebound, AnaptysBio's share price is far fr...
Despite a recent rebound, AnaptysBio's share price is far from regaining investors' confidence after substantial losses over the past five years. Market fears over consistent lack of profitability persist, despite revenue growth.
Investors in AnaptysBio (NASDAQ:ANAB) From Five Years Ago Are Still Down 74%, Even After 13% Gain This Past Week
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment